Our study complements prior studies which have reported the significance of stromal-derived CXCL12 signaling in driving the invasion and metastasis of prostate cancers [14,29], and provides a more-detailed understanding of how stromal-derived chemokine signaling may be induced. Here, CXCL12 is linked to prostate carcinoma.